検索キーワード： 身体的病い・疾患

Oral GLP-1 medications promise weight-loss results without needles, but can a daily pill with minimal absorption truly rival the proven power of weekly injections? Host Julia Cartwright unpacks the science, compares real-world trade-offs, and explores how new pricing models could finally make these drugs accessible to millions. For more content like this, visit QuietPlease.ai

Ozempic users are reporting unexpected hair loss, but is the drug itself to blame or the rapid weight loss it triggers? Host Julia Cartwright investigates the science behind the shedding, exploring clinical data, nutritional deficiencies, and what dermatologists recommend. Discover whether this side effect is temporary. For more content like this, visit QuietPlease.ai

Confused about how to bring up Ozempic with your doctor without sounding pushy or uninformed? Julia Cartwright gives you the exact preparation steps, word-for-word scripts, and follow-up strategies to turn an awkward request into a confident, productive medical conversation that respects both your goals and your doctor's expertise. For more content like this, visit QuietPlease.ai

Discover what Ozempic really costs without insurance—from the $1,000+ sticker price to hidden savings cards that drop it to $25. Host Pennie Power reveals discount programs, patient assistance options, and pharmacy strategies most people never hear about, helping you find an affordable path forward. For more content like this, visit QuietPlease.ai

Dr. Ben Synth unpacks the SURMOUNT-5 trial results comparing tirzepatide and semaglutide head-to-head in the largest obesity drug study ever conducted. Discover what 751 patients taught us about weight loss efficacy, cardiovascular benefits, and real-world tolerability differences that are reshaping clinical practice. For more content like this, visit QuietPlease.ai

Dr. Ben Synth investigates whether GLP-1 drugs like Ozempic cause cancer or prevent it, untangling rodent studies, FDA warnings, and surprising evidence that these medications might actually protect against obesity-related tumors. Discover why the truth is far more nuanced than headlines suggest. For more content like this, visit QuietPlease.ai

Could GLP-1 drugs like Ozempic increase cancer risk—or prevent it? Dr. Ben Synth cuts through contradictory headlines to examine thyroid warnings, surprising protective effects against obesity-related cancers, and how to interpret conflicting medical evidence. Learn what the science actually shows about these blockbuster medications and cancer. For more content like this, visit QuietPlease.ai

Explore the groundbreaking science behind GLP-1 drugs and addiction with Dr. Ben Synth. From shared brain reward pathways to landmark veteran studies, discover how medications for diabetes and weight loss may revolutionize treatment for alcohol, opioid, nicotine, and gambling addiction. Evidence-based insights into psychiatry's most promising frontier. For more content like this, visit QuietPlease.ai

Eli Lilly's orforglipron achieved 27 pounds of weight loss in trials, potentially revolutionizing obesity treatment with a daily pill that needs no refrigeration. Dr. Ben Synth examines the science behind oral GLP-1 drugs, their potential to democratize access worldwide, and the dangers of unregulated compounded alternatives that harmed hundreds of patients. For more content like this, visit QuietPlease.ai

Host Julia Cartwright examines clinical trial data and real-world studies to answer the question on everyone's mind: how much weight can you actually lose on Ozempic? From month-by-month timelines to individual variations and the less-publicized downsides, this series separates realistic expectations from social media hype. For more content like this, visit QuietPlease.ai

Host Pennie Power cuts through the confusion surrounding Medicare's 2026 GLP-1 Bridge Program, revealing which weight loss medications actually qualify, who's eligible based on BMI and health conditions, and the real costs beyond the $50 copay. Get the facts you need before coverage launches. For more content like this, visit QuietPlease.ai

The GOG Foundation, Inc. and GOG Partners are thrilled to share enduring education from Industry Supported Symposia that showcases clinical trials and other newsworthy education, from major medical meetings throughout the year.

Discover the science behind GLP-1 drugs like Ozempic, Wegovy, and Mounjaro with Dr. Ben Synth. Understand how these medications work at the molecular level, why they're so effective for weight loss and diabetes, and what the expanding research means for conditions from heart disease to Alzheimer's. For more content like this, visit QuietPlease.ai

Dr. Ben Synth investigates whether Ozempic truly causes pancreatitis by examining conflicting clinical data—from trials showing near-identical rates to studies claiming ninefold risk increases. He explains why diabetics already face elevated baseline danger and identifies who should reconsider treatment before their first injection. For more content like this, visit QuietPlease.ai

Wealth and Hellness takes an intimate look into the state of our current healthcare system and the multi trillion dollar health and wellness industry that accompanies it and often files patients into it. We breakdown structural issues within the system and what values lie below those issues while brushing on topical questions like should I be taking vitamins??? At the end of the day you will come away from this podcast more discerning of misinformation put out by this booming industry and more empowered to pursue true health and wellness for yourself.

Host Julia Cartwright dissects official medical reports and boasts about cognitive tests, consulting independent doctors to separate political spin from clinical reality. What do Trump's health disclosures reveal—and what critical information remains hidden as the oldest president in history governs into his eighties? For more content like this, visit QuietPlease.ai

Host Alexandra Reeves cuts through viral hoaxes and social media noise to investigate what's really known about President Trump's health in 2026. From debunked hospital rumors to documented physical symptoms, this series separates medical facts from internet speculation and examines why presidential health transparency matters more than ever. For more content like this, visit QuietPlease.ai

Talking Urology is a medical podcast series designed for urologists and healthcare professionals. It features expert interviews discussing landmark papers and developments in urological research. The podcast covers topics such as bladder cancer, prostate cancer, and functional urology.

Paradoxes of Gender – Episode 26.76: Today’s Podcast: Paradoxes of Gender Episode 26.76Interview with the Clinical Director from a Specialized Gender Clinic in the Netherlands. Zofia Radoslaw is the founder of Imago, which is arguably the only existing hub of professional services dedicated to the care of transgender people, by transgender people, in Western Europe. At its core, Imago’s mission is to provide professional psychological therapies and support, in addition to gender affirming hormonal treatment services, to thousands of European transgender individuals within an ...

Silsden Pharmacy is a trusted community pharmacy serving residents in Silsden, Keighley, and nearby areas of West Yorkshire. The pharmacy provides a wide range of NHS and private healthcare services designed to make everyday health support simple and accessible. Services include Pharmacy First consultations, repeat prescription support, weight management guidance, travel vaccinations, blood pressure checks, contraception services, and minor ailment treatment. The experienced pharmacy team offers professional advice, confidential consultations, and convenient walk-in care for many common health...